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The effects of adenosine and adenosine 5' -triphosphate
(ATP) on ventricular escape rhythms were studied in 16
closed chest dogs after electroablation of the His bundle
region. AU dogs exhibited complete atrioventricular (AV)
block and stable ventricular escape rhythm with a mean
cycle length of 1,210 ± 80 ms and a QRS width of
91 ± 5 ms. Physiologic AV sequential pacing was op-
erative during experiments and was interrupted for rapid
( :S 1 second) administration of either adenosine or ATP
(3 ILmoVkg) into the right atrium. Adenosine and ATP
effectively depressed ventricular escape rhythms in a
. similar manner both qualitativelyand quantitatively (cycle
length from 1,210 ± 80 to 1,764 ± 132 ms and from
1,274 ± 84 to 2,000 ± 150 ms, respectively; each p <
0.01).
Adenosine and adenosine 5'-triphosphate (ATP) exert pro-
nounced effects on mammalian cardiac cellular electro-
physiology (for a recent review see Ref . 1) which are man-
ifest as depression of sinus node activity, as well as
atrioventricular (AV) node conduction and automaticity (2,3).
Very little is known regarding the effects of adenosine and
ATP on ventricular electrophysiology. Previous in vitro studies
investigated the effects of adenosine (4-7) and ATP (5) on
the automaticity of guinea pig right ventricular strips (4)
and canine Purkinje fibers (5,6). More recently, the negative
chronotropic effects of adenosine and some of its analogs
were studied in spontaneously beating, isolated , isovolumic
rat ventricular preparations (7). The purpose of this study
was to investigate the effects and mechani sms of action of
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These effects were not significantly altered by either
physostigmine (an acetylcholinesterase inhibitor) or
atropine (a muscarinic cholinergic blocker), but were
slightly attenuated by propranolol (a beta-adrenoceptor
blocker). In the presence of autonomic blockade, the
adenosine transport blocker dipyridamole markedly en-
hanced the depressant effectsof adenosine and ATP. The
adenosine competitive antagonist aminophylline reo
versed the action of dipyridamole. Thus, both adenosine
and ATP depress ventricular escape rhythms in vivo,
independent of the autonomic nervous system. More-
over, the effects of ATP can be accounted for in large
part by its rapid breakdown to adenosine.
(J Am Coli CardioI1986;8:114S-S1)
adenosine and ATP on ventricular escape rhythms using
various pharmacologic interventions in the canine heart in
vivo .
Methods
Experimental preparation. Sixteen mongrel dogs (15
to 25 kg; either sex) were anesthetized with sodium pen-
tobarbital (30 mglkg body wieght , intravenously) , intubated
with a cuffed endotracheal tube and ventilated with room
air, supplemented as necessary with oxygen, using a Har-
vard respirator. A large bore (1.5 mm) catheter cannula was
introduced into the right atrium through the right femoral
vein. A quadripolarelectrode catheter was introduced through
the left femoral vein and positioned in the right atrium for
recording and pacing . A second quadripolar electrode cath-
eter was introduced through the right jugular vein and placed
in the right ventricle for recording and pacing. A tripolar
electrode catheter was introduced into the left carotid artery
and was positioned in the region of the noncoronary cusp
of the aortic valve for recording His bundle activity and for
ablation of the His bundle region . Systemic arterial pressure
was recorded with a Millar catheter tip electrotransducer
introduced through the left femoral artery .
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His bundle ablation (8) was achieved by delivering a
direct current electrical discharge (100 to 120 W·s) between
that lead of the tripolar His catheter that yielded the maximal
unipolar His bundle potential and a ground plate in contact
with the dog's back using a standard direct current defi-
brillator (Narco Scientific Porta-Fib LPDII). To minimize
the biochemical and electrophysiologic alterations associ-
ated with electrical shocks, only those dogs that exhibited
ventricular escape rhythms after no more than two ablation
attempts were included in this study. A ventricular escape
rhythm was defined as: (1) a stable rhythm of infranodal
origin with ventricular activation not preceded by His bundle
activity, and (2) independence of atrial and ventricular ac-
tivity (complete AV block). At the end of each experiment
the heart was surgically exposed, the position of the His
bundle catheter was confirmed and the gross morphologic
location and size of the electrically induced lesion were
examined.
Drug administration. Animals were left to stabilize for
1 hour after ablation. During that period AV sequential
pacing (cycle length = 600 ms; AV interval = 100 ms)
Figure 1. Typical example of a stable ventricular escape rhythm
after electroablation of the His bundle. Tracings are, from top to
bottom, lead II electrocardiogram (ECG II), right atrial electro-
gram (RA), His bundle electrogram (HBE) and right ventricular
electrogram (RV). A, Baseline conditions, before ablation. B, One
minute after ablation. C, Sixty minutes after ablation. Paper speed
was 100 mm/s in A and 25 mmls in Band C. A,H,P and V =
right atrial, His bundle, P wave and right ventricular activation,
respectively.
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was operative. Pacing was gradually interrupted for 90 sec-
onds, including 30 seconds before and 60 seconds after the
administration of either adenosine or ATP (3 Itmollkg).
These were administered as a very rapid (:51 second) bolus
injection into the right atrium in the absence of any other
drug and in the presence of each of the following drugs,
administered intravenously, sequentially in each animal:
physostigmine (an acetylcholinesterase inhibitor, 50 ltg/kg),
atropine (a muscarinic cholinergic blocker, 0.2 mg/kg), pro-
pranolol (a beta-adrenoceptor blocker, 1 mg/kg), dipyrid-
amole (an adenosine transport blocker, 250 ltg/kg) and
amiophylline (an adenosine competitive antagonist, 5 mglkg).
In the presence of dipyridamole, both adenosine and ATP
produced prolonged cardiac asystole; therefore, cardiac pac-
ing was instituted arbitrarily before the recovery of the ven-
tricular pacemaker to avoid hemodynamic deterioration.
Recordings. Sequential AV pacing was performed with
a programmed cardiac stimulator (Bloom Associates, Ltd.).
Cardiac electrograms, standard electrocardiographic lead II
and arterial blood pressure were continuously displayed on
an HP 1308A monitor and recorded with a Hi-Fi instru-
mentation tape recorder (HP 3968A) as well as a chart
recorder (Siemens Elema E183) at paper speeds of 25 to
100 mm/s. Arterial blood pH and gases were determined
every 20 minutes using a blood gas analyzer (Coming 168).
Data analysis. The depressant effects of adenosine and
ATP on ventricular escape rhythms were determined from
the maximal prolongation (in milliseconds) of ventricular
escape rhythm cycle lengths after the administration of these
compounds. For this purpose the single largest RR interval
during a regular rhythm was used in each case. These effects
were also expressed as percent of the ventricularcycle length,
where 100% represented the cycle length before the admin-
istration of either adenosine or ATP.
Data are presented as mean ± SEM. Analysis of variance
and corrected t tests for paired and unpaired samples were
used to determine significance of results at the p < 0.05
level. Experiments conformed to the "Guide for the Care
and Use of Laboratory Animals" of the American Phys-
iological Society and the Lankenau Animal Care Policy.
Results
Electrical ablation of His bundle. In all dogs, gross
morphologic examination performed at the end of experi-
ments revealed extensive damage to the His bundle region.
In addition, His bundle activation could not be detected in
the His bundle electrogram in any dog after either one
(n = 11) or two (n = 5) ablation attempts. All animals
had a stable ventricular escape rhythm with a mean cycle
length of 1,210 ± 80 ms (Fig. 1). In each case these rhythms
exhibited overdrive suppression (9); namely, after abrupt
termination of ventricular pacing at a rate greater than ven-
tricular escape rhythm, there was a transient pause in au-
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Figure 2. The percent maximal depressant effects of adenosine
and adenosine 5'-triphosphate (ATP) on ventricular escape rhythm
before and after sequential administration of various pharmaco-
logic agents . The ventricular cycle length (CL) before adminis-
tration of either adenosine or ATP was taken as I()()%. A =
atropine; AM = aminophylline; C = control ; D = dipyridamole;
P = propranolol ; PS = physostigmine .
tomatic activity (that is. an escape interval longer than the
baseline RR interval) , subsequent resumption of the dom-
inant ventricular escape rhythm at a rate slightly slower than
basel ine with gradual "warm-up" over several beats and
return to the baseline RR interval. Electrocardiograms showed
complete AV block and a QRS width of 91 ± 5 ms . Sinus
rhythm cycle length was 385 ± 16 ms before and 366 ±
13 ms after ablation (p = NS).
Effects of adenosine and ATP on ventricular escape
rhythms. Both adenosine and ATP had similar transient
depressant effects on ventricular escape rhythms (Fig. 2).
Ventricular pacemaker cycle length was prolonged from
o ADENOSINE 1,210 ± 80 to 1,764 ± 132 ms by adenosine and from
1,274 ± 89 to 2,000 ± 150 ms by ATP (each p <0.01).
The time to peak effect was 23 ± 2 seconds after the
administration of adenosine and 23 ± I seconds after ATP
admini stration. and returned to baseline over the next 60
second s. In many cases the maximal effects of adenosine
and ATP coincided with abrupt changes in QRS configu-
ration , suggesting the unmasking of a latent , subsidiary
pacemaker, although an effect on intraventricular conduc-
tion cannot be excluded (Fig. 3) .
Influence of vagoactive drugs. Neither the acetylcho-
linesterase inhibitor physostigmine nor the muscarinic cho-
linergic blocker atropine had a significant effect on the cycle
length of the ventricular escape rhythms. Moreover, neither
altered the depressant effects of either adenosine or ATP on
ventricular escape rhythms (Fig. 2). In the presence of phy-
sostigmine . ventricular cycle length was prolonged from
1.284 ± 91 to 1,831 ± 195 ms by adenosine and from
1,261 ± 72 to 2,194 ± 371 ms by ATP. Subsequent admin-
istration of atropine did not alter this pattern significantly;
ventricular pacemaker cycle length was prolonged from
1,319 ± 95 to 1,762 ± lSI ms by adenosine and from
1,312 ± 114 to 1,837 ± 153 ms by ATP.
Influence of beta-adrenoceptor blockade. In contrast
. to physostigmine and atropine , administration of propran-
olol significantly prolonged the ventricular pacemaker cycle
length from 1,319 ± 195 to 1,870 ± 170 ms (p < 0.05 ).
even before the administration of either adenosine or ATP.
Characteristically, this was accompanied by alteration of
the QRS configuration, suggesting either the emergence of
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Figure 3. A typical example of the
negative chronotropic effects of aden-
osine and adenosine 5' -triphosphate
(ATP) on ventricular escape rhythms .
Tracings are arranged as in Figure I .
A, Control . before administration of
drugs . B, Transient effects of aden-
osine (3 ILmoUkg) administered rap-
idly into the right atrium. Eight sec-
onds after administration of adenosine,
during which time the leading ven-
tricular pacemaker was gradually pro-
longed, a latent pacemaker emerged
or conduction alterations appeared
(filled arrows). or both. and were
manifest for 45 seconds . Note an " ec-
topic" beat (asterisk) just before the
return of the leading pacemaker 53
seconds after administration of aden-
osine. C, Similar effects and their
temporal pallem after administration
of ATP (3 ILmollkg). Symbols as in
B. An escape beat with a slightly dif-
ferent configuration is indicated by the
open arrows. Paper speed is 25 mm/
s. Abbreviations as in Figure I.
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by adenosine and from 1,730 ± 146 to only 2,466 ± 345
ms by ATP.
Discussion
The major findings of the present study are: l) Both
adenosine and ATP have pronounced depressant effects on
ventricular escape rhythms in vivo; 2) these actions of aden-
osine and ATP are similar both qualitatively and quantita-
tively; 3) there is no significant involvement of the vagus
in the effects of either adenosine or ATP; 4) beta-adreno-
ceptor blockade has only negligible influence on the actions
of adenosine and ATP; 5) the adenosine transport blocker
dipyridamole causes marked enhancement of the depressant
effects of adenosine and ATP on ventricular escape rhythms;
and 6) the competitive adenosine antagonist aminophylline
reverses these effects of dipyridamole.
Effects of adenosine and ATP on infranodal pace-
makers. Only five reports (4-7, 10) on the effects of aden-
osine on automatic activity of the mammalian ventricle are
available, each an in vitro study. No comparable information
is available on the effects of ATP. In earlier studies, the
effects of adenosine on the automaticity of guinea pig right
ventricular strips (4) and canine (5,6) Purkinje fibers were
evaluated. In these preparations adenosine caused pro-
nounced reduction in the spontaneous firing rate by reducing
the rate of phase 4 depolarization (4,5), and in paced canine
Purkinje fibers, adenosine also caused prolongation of the
escape interval (6). In the latter study (6), the action of
adenosine was abolished by propranolol, suggesting that the
effects of adenosine were mainly due to antiadrenergic ac-
tions. West et al. (10) reported that adenosine had a negative
chronotropic effect on ventricular escape rhythms in the
isolated guinea pig heart. More recently Heller and Olsson
(7) demonstrated that adenosine and some of its analogs
exerted negative chronotropic effects on the spontaneous
beating rate of an isolated, isovolumic rat ventricular prep-
aration.
Thus, the present study shows for the first time that
adenosine and ATP can suppress ventricular escape rhythms
in vivo. These results are in congruence with those of pre-
vious studies (7,10) mentioned earlier. In addition, in the
present study propranolol caused only a small attenuation
in the relative negative chronotropic action of adenosine and
ATP on ventricular escape rhythms. This argues against a
major indirect, antiadrenergic component in the mechanism
of action of adenosine and ATP. Although adenosine-cate-
cholamine antagonism has been shown in ventricular myo-
cardium in vitro (11), recent studies in vivo (12) indicated,
in agreement with the present findings, that adenosine did
not have any antagonistic effects on isoproterenol-induced
inotropy and chronotropy in the intact dog heart. This also
agrees with the lack of effect of propranolol on the action
of adenosine in vitro (7).
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a previously latent pacemaker or pronounced intraventric-
ular conduction alterations (Fig. 4). In the presence of pro-
pranolol the administration of adenosine resulted in further
prolonged ventricular escape rhythm cycle length from
1,870 ± 170 to 2,370 ± 258 ms. ATP similarly increased
the ventricular cycle length from 1,984 ± 211 to 2,304 ±
203 ms. Because the prolongation of ventricular cycle length
caused by propranolol was not accompanied by proportional
increases in the maximal prolongation caused by either aden-
osine or ATP, the relative effects of adenosine and ATP
showed a small but significant attenuation (Fig. 2).
Influence of an adenosine transport inhibitor. In the
presence of autonomic blockade the administration of the
adenosine transport inhibitor dipyridamole had no signifi-
cant effect on ventricular cycle length, but it markedly en-
hanced the depressant effects of both adenosine and ATP
on ventricular escape rhythm (Fig. 2). Ventricular cycle
length increased from 1,772 ± 182 to 4,499 ± 674 ms
after adenosine and from 1,531 ± 160 to 6,046 ± 1268
ms after ATP (each p < 0.0l). The difference in the absolute
or percent increase in cycle length for ATP versus adenosine
was not statisticially significant.
Influence of a competitive antagonist of adenosine.
Subsequent administration of aminophylline, a competitive
antagonist of adenosine, had no significant effect on ven-
tricular cycle length but resulted in pronounced attenuation
(p < 0.05) of the effects of both adenosine and ATP re-
corded previously in the presence of dipyridamole (Fig. 2).
In the presence of aminophylline, ventricular cycle length
was increased from 1,533 ± 133 to only 2,004 ± 200 ms
Figure 4. Typical example of the effectsof propranolol (I mg/kg)
on ventricular escaperhythms. Tracings are arranged as in Figure
1. A, Ventricular escape rhythm before propranolol (in the pres-
ence of physostigmine [50 j.tg/kg] and atropine [0.2 mg/kg]. B,
Five minutes after propronolol the leading ventricular pacemaker
is depressed and a stable latent pacemaker emerges. Note the
similarity between the QRS configuration of this pacemaker and
those transiently operative aftereither adenosine or ATPin Figure
2. Paper speed is 25 mm1s. Abbreviations as in Figure 1.
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Role of adenosine in the action of ATP. The time to
peak effect of adenosine and ATP on ventricular escape
rhythm was similar (23 seconds). This is longer than the
time to peak effect « 15 seconds) on the sinus and AV
nodes when adenosine and ATP are administered in the same
manner, also in the right atrium (13) . In view of the rapid
degradation of ATP to adenosine by ectoenzymes (14), the
relatively long time to peak effect of ATP suggests that the
action of ATP is mainly due to its breakdown to adenosine .
Thus, the fact that dipyridamole enhanced the effects of
both adenosine and ATP, whereas these were reversed by
aminophylline, indicates further that the major action of
ATP on ventricular escape rhythms is through its degra-
dation to adenosine. It has been previously shown that this
pattern of modulation by dipyridamole and aminophylline
is indicative of mediation by an extracellular R type puri-
noceptor (15). Dipyridamole was recently shown (16) to
have direct electrophysiologic effects on guinea pig papil-
lary muscle as well as canine Purkinje fibers. These include
increase in action potential amplitude and duration as well
as hyperpolarization of resting potential. The threshold for
these effects was 5 x 10- 7 M . Suppression of canine Pur-
kinje fiber automaticity was observed with 10-5 M dipyr-
idamole (16). The dose used in the present study could have
resulted in initial blood levels of approximately 5 x 10- 6
M . Therefore, although some effect on ventricular pace-
makers in our model cannot be excluded, a direct action of
dipyridamole cannot explain the pronounced enhancement
of the negative chronotropic action of both adenosine and
ATP.
Although the potential of methylxanthines to inhibit cyclic
AMP phosphodiesterase activity is well known (17), rela-
tively high concentrations (2:2 X 10- 4 M) of these agents
are required for this action (18, 19). The dose used in the
present experiments would have resulted in much lower
initial concentrations (-1 X 10- 4 M). Therefore, it is as-
sumed that inhibition of cyclic AMP phosphodiesterase is
not involved in the effects of aminophylline. Furthermore,
in a recent study (7), 10- 4 M theophylline in the presence
of propranolol inhibited the negative chronotropic action of
adenosine on ventricular rhythm as did its nonpermeating
analog 8-(4-sulfophenyl) theophylline. In further support of
the hypothesis that ATP is essentially devoid of depressant
effect on ventricular escape rhythms is the demonstration
by Rosen et al. (5) that a stable analog of ATP, /3-y-meth-
ylene-ATP, had no effect on the automaticity of Purkinje
fibers in vitro , whereas adenosine had significant depressant
effects.
Role of the vagus in the actions of adenosine and ATP.
The present study also shows that the vagus does not play
a major role in the action of ATP on ventricular escape
rhythms. This is in contrast to the previously established
role of the vagus in mediating the negative chronotropic and
dromotropic actions of ATP on the sinus and AV nodes in
a similar model (13,20) . The lack of signficant vagal in-
volvement in the negative chronotropic action of ATP on
ventricular escape rhythms is in agreement with the findings
of Spear and Moore (21). They showed, in a similar model,
that vagal stimulation had only a small depressant effect
(cycle length prolongation of about 7%) on ventricular es-
cape rhythms. The presence of such a small vagal effect
cannot be excluded by our data. Moreover, it is tempting
to speculate that a similarly small vagal input to the ventricle
was indeed triggered by ATP because the control negative
chronotropic effect of ATP on ventricular escape rhythms
was greater than that of adenosine and the difference was
of the same order of magnitude as the effect observed by
Spear and Moore (21). This speculation is supported by the
fact that physostigmine enhanced this difference and atro-
pine attenuated it. However, even in the presence of phy-
sostigmine the difference between the depressant effects of
ATP and adenosine was not statistically significant, thus
negating the importance of a possible ATP-triggered vagal
reflex component in the mechanism of action of ATP on
ventricular escape rhythms .
Previous studies (13,20) showed that, although adenosine
does not trigger vagal reflexes to the same extent as ATP,
vagal tone appears to modulate its actions on the sinus and
. AV nodes. Indeed, physostigmine enhanced the negative
chronotropic action of adenosine (20). In addition, the neg-
ative dromotropic action of adenosine was relatively more
pronounced in animals anesthetized with chloralose , a vagal
sparing agent, than in those anesthetized with pentobarbital ,
a vagolytic agent (22). No such vagal modulation was found
with respect to the negative chronotropic action of adenosine
on ventricular escape rhythms. Indeed, neither physostig-
mine nor atropine altered this effect of adenosine.
Experimental model and limitations. Electroablation
of the His bundle resulted in stable ventricular rhythms with
a mean rate of approximately 50 beats/min that were not
affected by either physostigmine or atropine but were slowed
by propranolol. These results are characteristic of ventric-
ular escape rhythms comparable with those previously re-
ported in similar models (21,23-26). The exact sites of the
ventricular pacemakers that were operative in the present
study were not determined . However, previous and present
data can support certain assumptions in this regard . Under
normal conditions ventricular pacemaker activity originates
in the His-Purkinje system . This seems to be the case in the
present study, because all ventricular escape rhythms ex-
hibited overdrive suppression, characteristic of normal au-
tomatic mechanisms . This observation is in agreement with
previous studies (27 ,28) that demonstrated overdrive
suppression of ventricular pacemakers . The rate of the ven-
tricular pacemaker in our study is similar to rates of normal
ventricular pacemakers observed in two previous canine
models (29,30). Moreover, faster rates, presumably result-
ing from abnormal automatic activity (or triggered activity)
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such as those reported in these canine models (29,30) were
not observed. It seems, therefore, that the different tech-
niques used in these two earlier studies (29,30) created
conditions that facilitated abnormal pacemaker activity.
In the present study various drugs were given sequentially
and it could be argued that this protocol affected the results
based on pharmacodynamic considerations. However, the
extremely short half-lives of adenosine and ATP «7 sec-
onds) enabled the rapid successive administration of these
compounds. Thus, the experimental protocol did not exceed
the shortest half-life of all the drugs (that is, that of atropine)
in this model. Indeed, we successfully used a similar pro-
tocol of pharmacologic interventions in previous studies
employing a similar canine model (13,20).
Clinical implications. It is tempting to speculate that
the negative chronotropic effects of adenosine and ATP on
ventricular automaticity in vivo could have potential clinical
relevance. This speculation is supported by a most recent
provocative clinical report of ventricular tachycardia re-
sponsive to adenosine (31). Thus, it could tum out that the
naturally occurring biologic compounds adenosine and ATP
can be used as antiarrhythmic drugs in the ventricles, in
addition to exerting their recognized antiarrhythmic effects
on paroxysmal supraventricular tachycardia incorporating
the AV node. Moreover, it is also tempting to speculate that
under conditions of ventricular ischemia in which release
of adenosine and ATP from myocardial cells is increased,
regional electrophysiologic properties are deranged and
autonomic tone is altered, adenosine and ATP may exert
either antiarrhythmic or arrhythmogenic effects of potential
clinical importance. However, the electrophysiologic effects
of adenosine and ATP in the setting of abnormal ventricular
rhythms have undergone only limited evaluation (32-35),
and further experimental as well as clinical studies are re-
quired to evaluate these hypotheses.
We thank Todor Mazgalcv, PhD for helpful comments. We are also grateful
to Carl Hurt, Wayne Klim and Rohn Price for assisting in the performance
of experiments and data analysis and to Rose Marie Wells for preparation
of the manuscript.
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